Literature DB >> 19132778

A case report of endocrine cell carcinoma in the sigmoid colon with inferior mesenteric vein tumor embolism.

Yusuke Tanoue1, Nobutaka Tanaka, Yoshio Suzuki, Shoujirou Hata, Aya Yokota.   

Abstract

We report a case of endocrine cell carcinoma in the sigmoid colon with inferior mesenteric vein (IMV) tumor embolism. A 79-year-old woman was admitted to our hospital with narrowing of the stools. We performed colonoscopy, computed tomography and positron emission tomography, which disclosed sigmoid colon cancer with IMV tumor embolism. She underwent sigmoidectomy and lymph node dissection. The tumor was diagnosed as endocrine cell carcinoma (type 4, pSS, med, INFalpha, v3, n1, stage IIIb). Immunohistochemically, chromographin A, synaptophysin, cytokeratin 20 and mucicarmine showed partial staining, and CD56 was totally reactive. Three months after operation multiple liver metastases appeared. She was treated with chemotherapy of cisplatin (CDDP) + irinotecan (CPT11). This case highlights the aggressiveness of endocrine cell carcinoma with tumor embolism, and it is essential to establish an accurate diagnosis and effective treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19132778      PMCID: PMC2653316          DOI: 10.3748/wjg.15.248

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

1.  Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.

Authors:  Kazumasa Noda; Yutaka Nishiwaki; Masaaki Kawahara; Shunichi Negoro; Takahiko Sugiura; Akira Yokoyama; Masahiro Fukuoka; Kiyoshi Mori; Koshiro Watanabe; Tomohide Tamura; Seiichiro Yamamoto; Nagahiro Saijo
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

2.  Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.

Authors:  C G Moertel; L K Kvols; M J O'Connell; J Rubin
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

3.  Small cell carcinomas of the large intestine.

Authors:  A B Burke; K M Shekitka; L H Sobin
Journal:  Am J Clin Pathol       Date:  1991-03       Impact factor: 2.493

4.  Gastric small cell carcinoma successfully treated by surgery and postoperative chemotherapy consisting of cisplatin and S-1: report of a case.

Authors:  Naohiko Koide; Akira Suzuki; Hiroyasu Saito; Toshiyuki Sato; Maki Murakami; Hiroyoshi Ota; Shinichi Miyagawa
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

5.  Carcinogenesis of gastric endocrine cell carcinoma: analysis of histopathology and p53 gene alteration.

Authors:  Ken Nishikura; Hidenobu Watanabe; Mitsuya Iwafuchi; Takato Fujiwara; Kazuko Kojima; Yoichi Ajioka
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

6.  Low colony formation in vivo and in culture as exhibited by metastatic melanoma cells selected for reduced homotypic aggregation.

Authors:  R Lotan; A Raz
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

7.  Primary small cell undifferentiated carcinoma of the rectum associated with ulcerative colitis.

Authors:  H Yaziji; W L Broghamer
Journal:  South Med J       Date:  1996-09       Impact factor: 0.954

8.  Neuroendocrine carcinomas of the colon and rectum.

Authors:  P E Bernick; D S Klimstra; J Shia; B Minsky; L Saltz; W Shi; H Thaler; J Guillem; P Paty; A M Cohen; W D Wong
Journal:  Dis Colon Rectum       Date:  2004-02       Impact factor: 4.585

9.  Small cell neuroendocrine carcinoma of the rectum.

Authors:  M Vilor; Y Tsutsumi; R Y Osamura; N Tokunaga; J Soeda; M Ohta; H Nakazaki; Y Shibayama; F Ueno
Journal:  Pathol Int       Date:  1995-08       Impact factor: 2.534

10.  Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin.

Authors:  E Mitry; E Baudin; M Ducreux; J C Sabourin; P Rufié; T Aparicio; T Aparicio; P Lasser; D Elias; P Duvillard; M Schlumberger; P Rougier
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

View more
  3 in total

1.  Local massive venous invasion in colorectal cancer: CT-pathological correlation and its clinical implication.

Authors:  I Nakajima; J Aoki; S Sakurai; H Naitoh; A Taketomi-Takahashi; Y Tsushima
Journal:  Br J Radiol       Date:  2015-01       Impact factor: 3.039

Review 2.  Colorectal neuroendocrine carcinoma: A case report and review of the literature.

Authors:  Tomoaki Yoshida; Kenya Kamimura; Kazunori Hosaka; Koji Doumori; Hiromitsu Oka; Akito Sato; Yasuo Fukuhara; Shoji Watanabe; Tomomi Sato; Akira Yoshikawa; Takashi Tomidokoro; Shuji Terai
Journal:  World J Clin Cases       Date:  2019-07-26       Impact factor: 1.337

3.  FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival.

Authors:  Anjili Mathur; Christopher Ware; Lenora Davis; Adi Gazdar; Bo-Sheng Pan; Bart Lutterbach
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.